Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Mankind Pharma Limited (NSE: MANKIND), ISIN INE634S01028 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
MANKIND last traded at ₹2465.00 (-0.60%), with a 52-week range of ₹1909.90 to ₹2640.30 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 72.63%, FIIs 9.45%, DIIs 15.39%, mutual funds 10.87%.
EquiSense Score (ECS): 76/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.